Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

  • STATUS
    Recruiting
  • End date
    Dec 31, 2022
  • participants needed
    950
  • sponsor
    University of Rochester
Updated on 22 May 2021

Summary

The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe.

Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who have a high risk of infection from COVID-19.

The study lasts for up to 16 months.

Details
Condition COVID19
Treatment COVID-19 RT-PCR test, COVID-19 Vaccine Education Campaign
Clinical Study IdentifierNCT04887129
SponsorUniversity of Rochester
Last Modified on22 May 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Students
IDD Student of the Mary Cariola Center
Age 3 - 18
Have a parent/guardian who can give informed consent
In the judgement of the Mary Cariola Medical Staff will be able to safely participate in the study procedures (nasal swab, phlebotomy)
Staff
Age 18 - 72
Able give informed consent
Anticipated duration of remaining employment less than 1 month (e.g. retiring)
Must be willing to participate in RT-PCR and antibody testing

Exclusion Criteria

Students
Contraindication to nasal swab
Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis)
Staff
Contraindication to nasal swab
Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note